INTRODUCTION
B-cell chronic lymphocytic leukemia (CLL) is the most common hematological malignancy in the Western world 1 ; however, the molecular etiology and pathogenesis of CLL remains unknown but antigen exposure may play a role 2 . Normal B cell development and differentiation as well as CLL leukemogenesis are thought to be a multi-step process. Thus, CLL may represent an accumulation of several genetic alterations. CLL shows the highest incidence of familial leukemia and is believed to be polygenetic 3 . Although the cell of origin remains unknown, it is thought by some to arise in a CD5+ B cell splenic marginal zone subpopulation whose immunoglobulin genes encode for polyreactive IgM autoantibodies 4 , 5 .
Molecular cytogenetic abnormalities reported associated with CLL include 13q14 deletions 6, 7 .
A minimally deleted region (MDR) has been described and several genes in this region have been sequenced but no mutations in protein-coding regions have been identified 8 . However, mutations in miR-16 have been described 9 as well as reduction in the levels of expression in the majority of CLL patients 10 . The NZB mouse has been studied extensively as a model to investigate autoimmune diseases such as systemic lupus erythematosus (SLE) 11 12 , as well as a model for the B cell lymphoproliferative disorder, CLL 13 . In both the NZB and human CLL, the disease is late appearing and similar to a subset of CLL patients, NZB mice develop autoimmune hemolytic anemia (AIHA). As NZB mice age, they develop a monoclonal lymphoproliferative expansion characterized by increased numbers of CD5+ B220 dull B cells which are hyperdiploid 14 . In addition, the NZB malignant CD5+ B clones frequently have increased IL-10 production and development of CLL-like clones is associated with elevated IL-10 in crosses of NZB with DBA/2 15 . In contrast, the DBA/2 strain has very few CD5+ B cells and does not
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Microsatellite or simple sequence length polymorphisms (SSLP) are widely used in mouse genetics because they are numerous, highly polymorphic and widely dispersed throughout the genome 16 and these SSLP's have been used to create dense linkage maps for at least 12 inbred strains of mice. The commercial availability of primers and the PCR-based identification of SSLP chromosome markers make it feasible to systematically search the entire mouse genome for linkage. In the present study, we performed a genome-wide scan to identify loci for murine lymphoproliferative disease (LPD) and additional direct DNA sequencing analysis was conducted on a locus on mouse chromosome 14 with synteny to human 13q14.
MATERIALS AND METHODS
Mouse colony. A mouse breeding colony was established within the FDA facility at the NIH campus and all protocols were approved by the Animal Use Committee. New Zealand Black (NZB) and DBA/2 (DBA) male and female mice were purchased from the Jackson Laboratories (Bar Harbor, ME). These mice and their progeny were housed under uniform conditions in the disease free animal rooms at the FDA (Bethesda, MD,USA). Male and female NZB and DBA/2 individuals were mated to produce a group of F1 individuals (NZB x DBA/2). F1 individuals were then backcrossed to NZB individuals to produce the population of [(NZB x DBA/2) F1 x NZB]. Animals were aged in single sex groups of ten. A total of 202 F1BC (read F1 back cross) animals were phenotyped of which 74 were positive microscopically for the presence of B cell LPD within the spleen. Additional subsequent crosses between NZB and DBA/2 were performed involving 230 additional study animals.
Phenotyping of Mice.
For personal use only. on October 28, 2017 . by guest www.bloodjournal.org From Autopsy. At the time of these studies, the mice were between 21-27 months of age. Animals were bled under light anesthesia [Metofane® (methoxyflurane, Pitman-Moore, Mundelein, IL,USA)] followed by cervical dislocation, peritoneal lavage and autopsy. The animals' total weight, sex, state of health and spleen weight were noted. Sections were obtained from the sternum, heart, lungs, salivary glands, liver, spleen, both kidneys, lymph nodes, and intestines for histological evaluation.
Histopathology. Tissue samples for microscopic examination were formalin fixed, paraffin embedded, sectioned and stained with H and E (EPL, Vienna, VA,USA). Spleens were systematically reviewed for overall size, pattern of the periarteriolar lymphoid sheath (PALS), number and size of germinal centers (GC), degree of extramedullary hematopoiesis (EMH), and whether GCs were inactive or reactive. LPD was classified as previously reported [17] [18] [19] .
Histology was performed using a Zeiss, model Axiophot microscope (Carl Zeiss, Inc., Thornwood, NY,USA) using a 5x objective with a 0.16 numerical aperture. The appearance of the bridging of two germinal centers by marginal zone cells was defined as minimal LPD or early spleen marginal zone lymphoma. Moderate involvement was infiltration of the red pulp by these marginal zone cells. Marked involvement was complete replacement of normal splenic architecture. A 40x objective (0.5-1.0 numerical aperture) was employed for nuclear morphology analysis. Photomicrographs were produced with a Cool Snap model HQ camera (Princeton Instruments, Trenton, NJ,USA) and the software for acquisition was IPLab (BD Biosciences, Rockville, MD,USA).
Blood. Blood was obtained from mice anesthetized with Metofane® via brachial artery exsanguination or cardiac puncture. This blood was used for a complete blood count (CBC), reticulocyte count, blood film and serum immunoglobulin levels (Analytics, Gaithersburg, Thirty-five cycles were used of 2 min. 94°C, 2 minutes at 56 to 62°C, and 30 sec. at 72°C.
Reactions were 20 µl volumes covered with oil in a microtiter plate. A hot start of 2 min. at 98°C was followed by the addition of enzyme at 85°C. The PCR products were resolved on a 3%
Metaphor (Cambrex Corp formerlyFMC Inc., Rockland, ME,USA) agarose gel stained with ethidium bromide. For the 75 loci chosen for this study, the longest distance between a marker and an autosomal locus was 15.8 cM. The X chromosome was not evaluated.
Linkage analysis. For all linkage analysis studies using the informative primer pairs, three DNA controls were used: NZB parental, DBA/2 parental and F1 (NZB xDBA/2) DNA. The F1 would and relative quantification study was performed on the RT products according to the manufacturer's protocol. Northern analysis was also performed and the level of expression reported as normalized fmol (normalized to the median of tRNA signals).
To study the effects of exogenous miR-16, a total of 1-4 million LNC cells were transfected with a microRNA mimic using the using the Amaxa Nucleofector II. Experimental 6 cells were stained with hypotonic PI (0.05mg/ml PI, 0.1% Triton X-100).
FACS data was acquired on Becton Dickinson FACS Calibur. Acquisition was done using CELLQUEST software (Becton Dickinson), and analysis was performed using ModFit LT software (Veriety House Inc).
RESULTS

Phenotype of F1Backcrosses.
Based on the results of the phenotypic analysis of 202 mice examined the backcross mice were divided on the basis of the presence or absence of LPD (non-LPD and LPD) (Fig 1, Table 1 ). Enlarged spleens were present in both LPD and non-LPD mice, however greatly enlarged spleens are more frequently seen in LPD mice (55% versus 24%, see Table 1 ). Based on RBC, MCV, and percent reticulocytes there was no significant difference in the presence of autoimmune hemolytic anemia in LPD versus non-LPD mice. However, leukocytosis was more frequent in the LPD mice (17% versus 3%, see Table 1 ), and lymphocytosis was confirmed by review of the blood film. Peritoneal cell count and serum IgM mean levels are nearly identical and do not suggest a disease related difference. Table 2 suggests that there is an increase in aneuploidy in the LPD F1BC animals.
Histopathology. In all, 37% (74/202) of the mice demonstrated LPD. Ninety-four percent (94%)(67/71) of the splenic murine lymphomas were classified as marginal zone lymphomas (MZL). Various stages of marginal zone involvement could be seen (Fig 2) : early marginal zone hyperplasia (Fig 2A-2B) ; the confluence of two or more germinal centers; massive infiltration of the red pulp ( Fig 2B/C) ; and the entire replacement of the spleen (Fig 2D) . Higher power views of tumor involved areas showed cellular details (Fig 2E-2H) . The marginal zone cells were characterized as monocytoid lymphocytes with clumped chromatin and a slight nuclear (Fig 2E/F) . The nuclear pattern became more vesicular in some mice (Fig 2G/H) .
This cellular spectrum suggests heterogeneity and marginal zone transformation. Other lymphocytic neoplasms (less than 5%) identified in mice with LPD included were lymphoplasmocytic lymphoma (2 cases) centroblastic lymphoma (one case) and small lymphocytic lymphoma (one case).
Flow Cytometric Analysis. Flow cytometric data from 12 representative F1BC mice with LPD as defined by histopathology are presented in Figure 3 . Hyperdiploidy was detected in both spleen and peritoneal cavity cells (Fig 3 A/B ), but not all mice with LPD had detectable aneuploidy. Further, the hyperdiploid cells were IgM positive B cells (Fig 3 C/D In contrast, mouse #4 clearly demonstrates a dominant hyperdiploid B clone in the spleen which is lacking in the peritoneal cells (Fig. 3 B and D) . Three color analysis of surface marker (Fig   3E/F) expression indicates that the aneuploid population is within the IgM+, CD5 dull+, B220 dim+ population.
Genomic Screening. In order to establish linkage between disease phenotype and genetic loci, informative polymorphic microsatellite regions were identified. To establish a linkage map, 450 SSLP were screened. Only 75 primers were informative with a minimum coverage of 15.8 cM.
For (Fig 4) . There was a point mutation in the NZB in the flanking region 3' to the stem loop structure of the pre-mir16-1. This mutation was not found in the DBA2 or other mouse strains (tissues/cell lines from C57Bl/6,SJLJ, NZW, Balb/c, NOD/SCID data not shown). This mutation was observed in multiple tissue sources of DNA derived from the NZB as well as DNA from two in vitro cell lines established from NZB, the LNC (an NZB-derived malignant B cell line) 23 and 3C2 (an NZB derived CD8+ CTL line) 24 ( Fig 4 and data not shown) . In both the NZB sequence and that reported for human CLL 9 , the mutation is in a nearly identical location in the 3'flanking region of mir-16-1 (Fig 4C) .
miR-16 Function Analysis in NZB:
The level of expression of miR-16 was investigated by realtime PCR and Northern analysis of RNA from several tissue sources derived from NZB and compared to the expression in the control C57Bl/6 or DBA/2 strains ( Table 3 and Fig 5) . NZB For personal use only. on October 28, 2017. by guest www.bloodjournal.org From tissue sources of RNA showed a decrease in miR-16 in spleen; however, the NZB kidney was not decreased in miR-16 expression compared to the control strain expression ( Table 3 ). In addition, the NZB derived malignant B cell line, LNC, had an even greater decreased expression of miR-16 compared to C57Bl6 spleen (Fig 5) . To study the effects of reconstitution of miR-16, electroporation was used to deliver either miR-16 or control mimic into the NZB line, LNC. Cell cycle and subG0/G1 accumulation were used to monitor the induction of apoptosis by miR-16 (Fig 6) . There was an increase in apoptosis following treatment with miR-16 and a decrease in cells in the S-phase. A non-NZB derived B cell line, NJ11107, did not demonstrate any effects following introduction of exogenous miR-16 (data not shown). As a control, both cell lines were transfected with pMax-EGFP vector and similar transfection efficiency was found (approximately 50%).
DISCUSSION
In the present report, genetic loci linked to the development of B cell malignancy was determined by using the NZB, a strain that develops a highly penetrant phenotype of B cell lymphoma and leukemia 18 (http://cancermodels.nci.nih.gov/mmhcc). We have described the phenotypic characterization and genomic analysis of NZB LPD in crosses of NZB and DBA/2 mouse strains 25 . The F1BC mice were derived from F1 crosses of NZB x DBA/2 and the F1 were backcrossed to the NZB parent. Aged F1BC mice were characterized for anemia, serum
IgM globulin levels, spleen histopathology, spleen cell DNA content and surface marker expression and a genomic scan was conducted using microsatellite polymorphism typing.
Splenic histopathology revealed LPD in 36.6% while splenic aneuploidy was found to be present in 43.2% in the F1BC colony. The majority of the F1BC mice that developed histopathological evidence of LPD were classified as marginal zone lymphomas expressing surface IgM, elevated However, chromosomal abnormalities are well known in CLL 6 . It would now seem that the MZL histopathology, aneuploidy and surface IgM, CD5 and B200 expression are linked to a region near D14Mit160 (D14Mit160 is approximately 11Mb from mir-16-1).
As noted above, the 13q14 site is frequently involved in human CLL and 13q14 deletions also occur in other closely related human LPD such as mantle cell lymphoma and multiple myeloma 26 . The process of leukemogenesis or lymphomagenesis is a multi-step process as evidenced by the fact that not all tumors in the F1BC were MZL but were rather other B cell There are a number of candidate genes on chromosomes 14, 18 and 19 located near the site of SSLP identified linkage. However, because of the synteny of the mouse chromosome 14
to the human 13q14, this loci was further studied. The significance of the other two loci on mouse chromosomes 18 and 19 remains to be determined. In the present study, identification of loci linked to the development of LPD in the NZB mouse model has been consistent with suggested tumor suppressor loci in human CLL. In particular, the linkage of lymphoproliferative disease with the mouse chromosome 14 (human 13q14) is not unexpected, since up to 50% of cases of CLL have a loss of human 13q14.3 26 . Two genes in this region have been shown to be highly conserved between mouse and humans, DLEU2 and RFP2 (also called LEU5) 27 . Despite the linkage to this particular region of DNA in CLL, no somatic mutations in this region have been detected in CLL patients 28 and none were found in the NZB strain of mouse (data not shown). In addition to the presence of DLEU2 and RFP2 in the human 13q14 and the region of synteny in the mouse chromosome 14, there are two microRNAs genes found in the intronic region of DLEU2 in both murine and human, mir-15a and mir-16-1.
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and mir-16-1 genes. Recent SNP array studies also found that mir15a/16-1 genes were the targets of the recurrent 13q14 deletions and strengthen the conclusion that these two microRNAs are critical genes for CLL pathogenesis 32 . Mutations in this region have been reported (reviewed in 31 ). In the present report, we describe a mutation in NZB in the immediate 3'flanking region of mir-16-1. Analysis of levels of mature miR-16 indicated decreased expression in NZB spleen as well as in the NZB derived malignant B cell line, LNC. The flanking region, containing the mutation, may be important for proper tertiary structure of the stem-loop in the pre-mir 33 . This is consistent with the finding reported by others of decreased miR-16 in some CLL patients 31 .
One possible outcome of decreased miR-16 is a failure to properly reduce target gene expression. The genetic linkage of autoimmune disease in the NZB has been studied extensively as a model for SLE 36, 37 , while the loci linked to leukemia and lymphoma have not been determined.
Based on our findings, the loci linked to LPD in NZB mice were not linked to previously identified loci linked to autoimmunity. In our present study, we found linkage to chromosomes 14, 18 and 19 in NZB. In other mouse CLL studies, transgenic mice derived by using the human TCL1 sequence (mouse homolog on chromosome 12), have been produced which develop a variety of B cell neoplasias including CLL, follicular lymphomas, Burkitt's lymphoma and diffuse large cell lymphomas; however, no linkage was found to this gene locus in the present study 38, 39 . It is of interest that a locus involving CD5 B cells in NZB has also been mapped to chromosome 4 but this was not linked to LPD in the present study 40 while a locus on chromosome 13 has been found to be linked to marginal zone hyperplasia in NZB mice 41 .
The results from this present study describe three loci in NZB mice linked to the development of B cell lymphoproliferative disease. The significance of two of these loci located on mouse chromosomes 18 and 19 remains to be determined. The third locus was found to be the site of a point mutation in a microRNA in NZB mice. Alterations in miRNA miR-16 levels may be an important factor in the development of both human CLL and the NZB mouse model since overexpression of miR-16 in an NZB cell line induces apoptosis. The NZB mouse, because it spontaneously develops B lymphoproliferative disease in an environment characterized by anti-self reactivity, can shed insight not only into disease mechanisms but also in the development of therapy targeted at the loci linked to the development of CLL. The sequences are identical to the reference sequence, except for a T→A point mutation (on the antisense strand; A →T point mutation at base 60585990 on the sense strand of chr 14) in the NZB/BlNJ. In addition, DNA extracted from DBA/2J (5wks) liver, NZW (5wks) spleen, Balb/C B cell lymphoma cell line (CH27), C57BL/6 (4mos) kidney, SJL/J B cell lymphoma line (NJ117), and NOD SCID (7mos) liver showed no point mutation, whereas DNA from NZB/BlNJ spleen, liver (14mos), kidney (15mos), T cell lymphoma line (3C2), and malignant B1 cell line (LNC) all had the same point mutation (data not shown). The precursor stem-loop structure sequences (pre-miRNA) are based on established nomenclature 20 . In the mouse samples (pre-mmu-mir) for both pre-mir-15a (Accession # MI0000564) and pre-mir-16-1(MI0000565) and mature sequences for both mir-15a (MIMAT0000526) and 16-1 For personal use only. on October 28, 2017 . by guest
